Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial
(Q38440924)
scientific article
scientific article
Language:
other details
| description | scientific article |
External Links
| (P356) |
10.1161/CIRCULATIONAHA.113.007012
|
| (P698) |
24255061
|